Mandatum Life Insurance Co Ltd Makes New Investment in GE HealthCare Technologies Inc. $GEHC

Mandatum Life Insurance Co Ltd acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 100,037 shares of the company’s stock, valued at approximately $7,513,000. GE HealthCare Technologies makes up 1.8% of Mandatum Life Insurance Co Ltd’s investment portfolio, making the stock its 11th biggest holding.

A number of other large investors also recently modified their holdings of the company. Allianz SE lifted its holdings in shares of GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after acquiring an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. lifted its stake in GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after purchasing an additional 196 shares during the last quarter. Godsey & Gibb Inc. bought a new stake in GE HealthCare Technologies in the third quarter worth $26,000. Oakworth Capital Inc. boosted its position in GE HealthCare Technologies by 1,876.2% during the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after buying an additional 394 shares during the period. Finally, Gladwyn Financial Advisors Inc. bought a new position in shares of GE HealthCare Technologies during the second quarter valued at about $34,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. The Goldman Sachs Group restated a “buy” rating and set a $98.00 price target on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Bank of America lifted their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Citigroup increased their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Finally, Morgan Stanley upped their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $79.08 on Tuesday. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The firm’s fifty day simple moving average is $82.73 and its 200 day simple moving average is $77.57. The stock has a market cap of $36.04 billion, a P/E ratio of 17.34, a price-to-earnings-growth ratio of 1.75 and a beta of 1.09. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is currently 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.